1 of 1
Story summary
- The gut microbiome plays a vital role in cancer treatment and prevention, affecting therapy responses and being influenced by diet.
- Research shows gut microbes impact the effectiveness of chemotherapy and immunotherapy, supported by emerging human data.
- Current recommendations suggest reducing processed meat and increasing fruits and vegetables for better cancer prevention.
- Engineering the microbiome, like fecal microbiota transplantation (FMT), shows potential but carries risks for immunocompromised patients.
- Dysbiosis can disrupt immune signaling and promote inflammation, contributing to cancer development.
